Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients

Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association
B ZietzA Schäffler

Abstract

The peroxisome proliferator-activated receptor-gamma2 (PPAR(gamma2)) represents the transcriptional master regulator of adipocyte differentiation and therefore has been suggested as candidate gene for the pathogenesis of obesity, type 2 diabetes and related metabolic disorders. Aim of our study was to determine the frequency of a missense point mutation within exon 2 of PPAR(gamma2), Pro12Ala, and its possible association with metabolic parameters as well as diabetic retinopathy (in a population-based sample of 560 (318 male ad 242 female) type 2 diabetic patients. Subsequent to genomic PCR amplification, the Hpa-II RFLP analysis was used for genotyping. 436 (77.9%) subjects were homozygous for the wildtype allele (Pro/Pro), 118 (21.1%) were heterozygous (Pro/Ala) and 6 (1.1%) were homozygous for the mutated allele (Ala/Ala). Genotype frequency was calculated to be 0.81 for the wildtype and 0.19 for the mutated allele. These frequencies did not differ from non-diabetic cohorts examined earlier. In contrast to females, total cholesterol and LDL-cholesterol were significantly higher in males (Total cholesterol: 281.8 +/- 51.3 vs 253.1 +/- 49.8 mg/dl, p < 0.0001; LDL-cholesterol: 182.0 +/- 49.2 vs 155.6 +/- 42.0 mg/d, p < 0.0001) ...Continue Reading

Citations

May 27, 2003·Molecular Genetics and Metabolism·Virpi LindiUNKNOWN KANWU Study Group
Jul 22, 2008·Neurobiology of Aging·Nancy A WestHal Morgenstern
Apr 24, 2018·Acta Ophthalmologica·Suzanne BroadgateVictor Chong
Oct 28, 2017·Molecular and Cellular Biochemistry·B Grygiel-GórniakJ Nowak
Mar 14, 2003·Obesity Research·Yvon C ChagnonClaude Bouchard
May 10, 2016·Endocrine Reviews·Alexandra Kautzky-WillerGiovanni Pacini
Dec 13, 2003·The Journal of Clinical Endocrinology and Metabolism·Francesco OrioGaetano Lombardi
Oct 25, 2002·Diabetes/metabolism Research and Reviews
Sep 2, 2016·Journal of Biosciences·Bogna Grygiel-GorniakJerzy Nowak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.